Coagulation activity in bronchoalveolar lavage fluid and blood of interstitial lung diseases patients Source: Eur Respir J 2003; 22: Suppl. 45, 255s Year: 2003
Coagulation activity of bronchoalveolar lavage fluid and blood in patients with interstitial lung diseases Source: Eur Respir J 2002; 20: Suppl. 38, 174s Year: 2002
Comparison of cellular composition of induced sputum, bronchial washing and bronchoalveolar lavage fluid in some interstitial lung diseases Source: Eur Respir J 2002; 20: Suppl. 38, 313s Year: 2002
Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019
Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012
Interleurin-4 and immunoglobulin E levels in bronchoalveolar lavage fluid and blood serum in patients with bronchial asthma and lung tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001
Haemoxygenase-1 expression in broncho-alveolar lavage fluid alveolar macrophages is diminished in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002
The decrease of surfactant protein D in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012
Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease Source: ERJ Open Res, 8 (1) 00481-2021; 10.1183/23120541.00481-2021 Year: 2022
The coagulation and antifibrynolitic activities are increased in the bronchoalveolar lavage fluid from patients with progressing idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 575s Year: 2007
Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013
Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 586s Year: 2007
Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001
Net inflammatory activity of bronchoalveolar lavage fluid (BALF) from patients following lung transplantation Source: Eur Respir J 2002; 20: Suppl. 38, 348s Year: 2002
ECP and EPX in bronchoalveolar lavage fluid in children with cystic fibrosis and mild lung disease Source: Eur Respir J 2001; 18: Suppl. 33, 538s Year: 2001
Activity of neutrophils in bronchoalveolar lavage fluid in children with chronic bronchiolitis and asthma Source: Eur Respir J 2001; 18: Suppl. 33, 272s Year: 2001
Profile of antimicrobial peptides in the bronchoalveolar lavage of patients with interstitial lung diseases Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis Year: 2021
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005
The relationship between the course of sarcoidosis and changes of markers of the disease activity in a bronchoalveolar lavage fluid Source: Eur Respir J 2002; 20: Suppl. 38, 469s Year: 2002
The comparison of imbalance in protease/antiprotease system in bronchoalveolar lavage fluid of children with chronic bronchiolitis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 194s Year: 2002